INFINITY MULTIVIEW INFINITY TELEMETRY SYSTEM

K033305 · Draeger Medical Systems, Inc. · DSI · Oct 31, 2003 · Cardiovascular

Device Facts

Record IDK033305
Device NameINFINITY MULTIVIEW INFINITY TELEMETRY SYSTEM
ApplicantDraeger Medical Systems, Inc.
Product CodeDSI · Cardiovascular
Decision DateOct 31, 2003
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 870.1025
Device ClassClass 2
AttributesPediatric

Intended Use

The INFINITY MultiView WorkStation, INFINITY Network and Remote Display are indicated for use as a central monitoring device, communications network, and remote display for Draeger Patient Monitoring Systems and recorders. The INFINTY MultiView WorkStation (MVWS) Telemetry System is intended to measure and produce visual and audible alarms for one or more physiological parameters. The INFINITY MultiView WorkStation with Rest ECG can provide interpretive diagnostic statements and reports when connected to a monitor with ECG monitoring capability. The INFINTY MVWS telemetry System with TruST is intended for 12-Lead ECG monitoring with a reduced set of electrodes. Reconstructed leads are intended for real-time assessment of ST segment changes. This device is intended for use in an environment where patient care is provided by Healthcare Professionals, i.e. Physicians, Nurses, and Technicians, who will determine when use of the device is indicated, based upon their professional assessment of the patient's medical condition.

Device Story

The INFINITY MultiView WorkStation (MVWS) is a central monitoring system for physiological data. With VF4 software, it interfaces with Reynolds CardioCollect via RS232 to process Rest ECG reports. For TruST-monitored patients, the system acquires 12-lead ECG data and calculates patient-specific baseline coefficients. The device processes inputs to provide interpretive diagnostic statements, visual/audible alarms, and real-time ST segment analysis. Used in clinical environments by physicians, nurses, and technicians to monitor patient status and support clinical decision-making. The system benefits patients by enabling continuous monitoring and diagnostic reporting through a centralized workstation.

Clinical Evidence

No clinical data provided. Substantial equivalence is supported by internal design control testing and assessment of non-clinical performance data.

Technological Characteristics

Centralized physiological monitoring workstation. Software-based processing of ECG data and arrhythmia detection. Connectivity via RS232 for external device integration (CardioCollect). Operates as a networked system for remote display and alarm management. Not MRI compatible.

Indications for Use

Indicated for adult and pediatric patients requiring monitoring of heart rate, ECG arrhythmia, arterial oxygen saturation, pulse rate, and ST segment analysis. TruST feature indicated for 12-lead ECG monitoring using reduced electrode sets for real-time ST segment assessment. For use by healthcare professionals in clinical settings.

Regulatory Classification

Identification

The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs.

Special Controls

*Classification.* Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ K033305 # OCT 3 1 700 Special 510(k): Device Modifica INFINITY MultiView WorkStation TruST ## 1. 510(k) SUMMARY as required per 807.92(c) ## Submitters Name, Address: - Draeger Medical Systems, Inc. Danvers, MA 01923 Tel: (978) 907-7500 Fax: (978) 750-6879 Establishment Registration Number: 1220063 Official Correspondent: Connie Hertel, Director, QA/RA Contact person for this submission: Penelope H. Greco Date submission was prepared: October 13, 2003 Trade Name, Common Name and Classification Name: - A. Trade Name: INFINITY MultiView WorkStation - B. Common Name, Classification Name, Class and Regulation Number: | Common Name | Product Code | Class | Regulation Number | |--------------------------------------------------------------|--------------|-------|-------------------| | Detector and Alarm, Arrhythmia | MHX | III | 870.1025 | | System, Network and Communication,<br>Physiological Monitors | MSX | II | 870.2300 | Legally Marketed Device Identification: K030738 Infinity MultiView WorkStation Telemetry with TruST K023569 Infinity MultiView WorkStation VF3 Modifications K980625 Infinity MultiView WorkStation Enhanced with Rest ECG # Device Description: With the release of software version VF4, the Infinity MultiView WorkStation can receive ECG data sent from a Reynolds CardioCollect and process Rest ECG reports (K980625) when a CardioCollect is interfaced to a MultiView WorkStation via an RS232 connection. Additionally, when a 12-lead Rest ECG for a TruST monitored patient is successfully acquired and uploaded, the MultiView WorkStation calculates a set of baseline coefficients specific to each patient. Page 1 of 2 Draeger Medical Systems, Inc. 16 Electronics Avenue Danvers, MA 01923 Tel: (978) 907-7500 Fax: (978) 750-6879 {1}------------------------------------------------ The Indications for Use and Intended Use of the INFINITY MultiView WorkStation and Telemetry System have not changed with VF4 software. Testing has been performed in accordance with internal design control procedures and indicates no affect on the safety or efficacy of the MultiView WorkStation. ### Intended Use: The INFINITY MultiView WorkStation, INFINITY Network and Remote Display are indicated for use as a central monitoring device, communications network, and remote display for Draeger Patient Monitoring Systems and recorders. The INFINTY MultiView WorkStation (MVWS) Telemetry System is intended to measure and produce visual and audible alarms for one or more physiological parameters The INFINITY MultiView WorkStation with Rest ECG can provide interpretive diagnostic statements and reports when connected to a monitor with ECG monitoring capability. The INFINTY MVWS telemetry System with TruST is intended for 12-Lead ECG monitoring with a reduced set of electrodes. Reconstructed leads are intended for real-time assessment of ST segment changes. This device is intended for use in an environment where patient care is provided by Healthcare Professionals, i.e. Physicians, Nurses, and Technicians, who will determine when use of the device is indicated, based upon their professional assessment of the patient's medical condition. Assessment of non-clinical performance data for equivalence: Section J Assessment of clinical performance data for equivalence: Section J Biocompatability: Not applicable Sterilization: Not applicable Standards and Guidances: Section J Page 2 of 2 Draeger Medical Systems, Inc. 16 Electronics Avenue Danvers, MA 01923 Tel: (978) 907-7500 Fax: (978) 750-6879 {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol that resembles a stylized caduceus or a representation of the human form. Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 OCT 3 1 2003 Draeger Medical Systems, Inc. c/o Ms. Penelope H. Greco Regulatory Submissions Manager 16 Electronics Avenue Danvers. MA 01923 Re: K033305 Trade Name: INFINITY MultiView WorkStation & Telemetry System with VF4 Modifications Regulation Number: 21 CFR 870.1025 Regulation Name: Arrhythmia Detector and Alarm Regulatory Class: Class III (three) Product Code: DSI Dated: October 13, 2003 Received: October 14, 2003 Dear Ms. Greco: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ #### Page 2 - Ms. Penelope H. Greco Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4646. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely vours, Dina Husakuefor B.S., R.Z. de Leon, M.D. Bram D. Zuckerman. N Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ 510(k) Number (if known): ____________________________________________________________________________________________________________________________________________________ Infinity MultiView WorkStation & Telemetry System with VF4 Device Name: Modifications Indications for Use: The INFINITY MultiView WorkStation, INFINTY Network and Remote Display are indicated for use as a central monitoring device, communications network, and remote display for Draeger Patient Monitoring Systems and recorders. The INFINITY MultiView WorkStation with Rest ECG is intended to provide interpretive diagnostic statements and reports when connected to an ECG monitor. Use of the INFINITY MultiView WorkStation Telemetry System is indicated for adult and pediatric patient populations in an environment where patient care is provided by Healthcare Professionals (Physicians, Nurses, Technicians) when the professional determines that a device is required to measure and produce visual and audible alarms for any one or more of the following parameters: - Heart rate - . ECG Arrhythmia Analysis - . Arterial oxygen saturation - . Pulse rate - ST segment analysis . The INFINITY MultiView WorkStation (MVWS) Telemetry System with TruST is indicated for use when 12-Lead ECG monitoring with a reduced set of electrodes is desired. Reconstructed leads are intended for real-time assessment of ST segment changes. #### MRI Compatibility Statement: The Infinity MultiView WorkStation & Telemery Systems are not compatible for use in a MRI magnetic field. (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) | | Concurrence of CDRH, Office of Device Evaluation (ODE) | | |-----------------------------------|--------------------------------------------------------|--------------------------| | Prescription Use | | Over-The-Counter Use | | (Per 21 CFR 801.109) | | (Optional Format 1-2-96) | | (Division Sign-Off) | | | | Division of Cardiovascular Device | | | | 510(k) Number | 2033305 | |
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...